Frequently Asked Questions


Why don’t researchers just do the analysis on all the existing UK ME/CFS Biobank samples to see what it reveals first?

Existing samples from the UK ME/CFS Biobank will be used. However, we need a very large number of people for a GWAS study, typically at least 10,000–20,000 patients. This will require a significant expansion of the Biobank, and collaboration with the NIHR Biosample Centre in Milton Keynes.

Previous Why this particular approach over others?
Next Wouldn’t it be better to back research to find a reliable biomarker first, to ensure participants in this kind of study actually have ME/CFS?

The largest ever DNA study of ME/CFS

A partnership between

Action for ME logo
Forward ME Logo
UKRI MRC Human Genetics Unit logo
National Institute for health research